Tools for Practice Outils pour la pratique


#135 Corticosteroid shots and knees: A match made in osteoarthritis heaven?


CLINICAL QUESTION
QUESTION CLINIQUE
What is the effectiveness of intra-articular corticosteroid injections in knee osteoarthritis?


BOTTOM LINE
RÉSULTAT FINAL
Corticosteroid intra-articular knee injections reduce osteoarthritis pain ~40% more than placebo and one in every 3-5 patients injected will have global symptom improvement in the first four weeks. Long-term pain relief is less certain but serious adverse events, like joint infection, are very rare (one in >14,000).  



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
We found six systematic reviews,1-6 each with 5-13 Randomized Controlled Trials (RCTs) and 207-648 patients total. Comparing corticosteroid (triamcinolone 20-40 mg most common, methylprednisolone 40-120 mg next most common) to placebo injections.   
  • Pain: On a 100 point Visual Analogue Scale (VAS) steroids statistically significantly reduced pain (from ~54 baseline)4 more than placebo:  
    • 21-22 points lower at one week,1,2 16.5 points lower at two weeks,3 7.4 points at 3-4 weeks.1 
      • Average ~15 points better between 1-4 weeks.4 
    • At later time points, difference is non-statistically significant.1  
    • Maximal effect may occur at 1.5 weeks.4 
  • Pain: Hitting a particular pain reduction target or global improvement: 
    • 74-78% for steroid vs. 45-54% placebo.1-3  
      • Number Needed to Treat (NNT)=3-5, at 1-4 weeks.1-3 
    • Results at >4 weeks inconsistent: Two found no effect,1,2 one reports NNT=5 at 16-24 weeks.3    
  • Function and stiffness not reliably changed.5   
  • Issues: Included RCTs were frequently small (≤50) and often short (example one week). Pooled results also often included few studies and lacked power.1-6     
Context: 
  • Overall, corticosteroid injections may be most efficacious therapies for knee osteoarthritis in the first 1-4 weeks.4,5  
  • Unclear if one type of steroid better than another.7 
  • Maximum frequency ~4/year.  
    • RCT injected steroids 4x/year for two years without any harms.8 
    • Cohort of 4 injections/year found no harm.9 
  • Which clinical features influence success is unclear10,11 but increased radiographic severity may reduce effectiveness while increased clinical severity (pain and stiffness) may improve effectiveness.10 
  • Risk of joint infection one in 14,000-77,000 following intra-articular injection.12  
  • Guidelines generally recommend corticosteroid intra-articular injections,13,14 although uncertainty (due to insufficient long-term evidence) remains.15 


Latest Tools for Practice
Derniers outils pour la pratique

#367 Oral Calcitonin Gene-related Peptide Antagonists: A painfully long name for the acute treatment of migraines

What are the risks and benefits of ubrogepant for the acute treatment of episodic migraines?
Read Lire 0.25 credits available Crédits disponibles

#366 Looking for Closure: Managing simple excisions or wounds efficiently

What are some options for efficiency in wound closure?
Read Lire 0.25 credits available Crédits disponibles

#365 Shrooms for Glooms: Evidence for psilocybin for depression

What are the benefits and harms of psilocybin for treatment-resistant/recurrent depression?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • G. Michael Allan MD CCFP
  • Jeff Jamieson MD

1. Godwin M, Dawes M. Can Fam Physician. 2004; 50:241-8.

2. Bellamy N, Campbell J, Welch V, et al. Cochrane Database Syst Rev. 2006; (2):CD005328.

3. Arroll B, Goodyear-Smith F. BMJ. 2004 Apr 10; 328(7444):869.

4. Bjordal JM, Klovning A, Ljunggren AE, et al. Eur J Pain. 2007; 11:125-38.

5. Bannuru RR, Schmid CH, Kent DM, et al. Ann Intern Med. 2015; 162:46-54.

6. Hepper CT, Halvorson JJ, Duncan ST, et al. J Am Acad Orthop Surg. 2009; 17:638-46.

7. Garg N, Perry L, Deodhar A. Clin Rheumatol. 2014; 33:1695-706.

8. Raynauld JP, Buckland-Wright C, Ward R, et al. Arthritis Rheum. 2003; 48:370-7.

9. Balch HW, Gibson JM, El-Ghobarey AF, et al. Rheumatol Rehabil. 1977; 16:137-40.

10. Maricar N, Callaghan MJ, Felson DT, et al. Rheumatology (Oxford). 2013; 52:1022-32.

11. Hirsch G, Kitas G, Klocke R. Semin Arthritis Rheum. 2013; 42:451-73.

12. Jones T, Kelsberg G, Safranek S. Am Fam Physician. 2014; 90:115-6.

13. Hochberg MC, Altman RD, April KT, et al. Arthritis Care Res (Hoboken). 2012; 64:465-74.

14. Richmond J, Hunter D, Irrgang J, et al. J Am Acad Orthop Surg. 2009; 17:591-600.

15. Jevsevar DS, Brown GA, Jones DL, et al. J Bone Joint Surg Am. 2013; 95:1885-6.

Authors do not have any conflicts to disclose.